Ricardo Josué Romero-Moreno

Dr. Ricardo Josué Romero-Moreno

University of Notre Dame
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
RRRicardo Josué Romero-Moreno
Ricardo Josué Romero-Moreno
KCKimberly J. Curtis
Kimberly J. Curtis
TCThomas R. Coughlin
Thomas R. Coughlin
MMMaria Cristina Miranda-Vergara
Maria Cristina Miranda-Vergara
SDShourik Dutta
Shourik Dutta
LLLaurie Littlepage
Laurie Littlepage
Bone is one of the most common sites for metastasis across cancers. Cancer cells that travel through the vasculature and invade new tissues can remain in a non-proliferative dormant state for years before colonizing the metastatic site. Switching from dormancy to colonization is the rate-limiting step of bone metastasis. Here we develop an ex vivo co-culture method to grow cancer cells in mouse bones to assess cancer cell proliferation using healthy or cancer-primed bones. Profiling soluble factors from conditioned media identifies the chemokine CXCL5 as a candidate to induce metastatic colonization. Additional studies using CXCL5 recombinant protein suggest that CXCL5 is sufficient to promote breast cancer cell proliferation and colonization in bone, while inhibition of its receptor CXCR2 with an antagonist blocks proliferation of metastatic cancer cells. This study suggests that CXCL5 and CXCR2 inhibitors may have efficacy in treating metastatic bone tumors dependent on the CXCL5/CXCR2 axis.

21 February 2019 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
EBEun-Kyoung Breuer
Eun-Kyoung Breuer
DFDaniela Fukushiro-Lopes
Daniela Fukushiro-Lopes
ADAnnika Dalheim
Annika Dalheim
MBMiranda Burnette
Miranda Burnette
JZJeremiah Zartman
Jeremiah Zartman
SGSaverio Gentile
Saverio Gentile
Potassium ion channels are critical in the regulation of cell motility. The acquisition of cell motility is an essential parameter of cancer metastasis. However, the role of K+ channels in cancer metastasis has been poorly studied. High expression of the hG1 gene, which encodes for Kv11.1 channel associates with good prognosis in estrogen receptor-negative breast cancer (BC). We evaluated the efficacy of the Kv11.1 activator NS1643 in arresting metastasis in a triple negative breast cancer (TNBC) mouse model. NS1643 significantly reduces the metastatic spread of breast tumors in vivo by inhibiting cell motility, reprogramming epithelial–mesenchymal transition via attenuation of Wnt/β-catenin signaling and suppressing cancer cell stemness. Our findings provide important information regarding the clinical relevance of potassium ion channel expression in breast tumors and the mechanisms by which potassium channel activity can modulate tumor biology. Findings suggest that Kv11.1 activators may represent a novel therapeutic approach for the treatment of metastatic estrogen receptor-negative BC. Ion channels are critical factor for cell motility but little is known about their role in metastasis. Stimulation of the Kv11.1 channel suppress the metastatic phenotype in TNBC. This work could represent a paradigm-shifting approach to reducing mortality by targeting a pathway that is central to the development of metastases.

25 September 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Brandon CzowskiBrandon Czowski
Brandon Czowski
RRRicardo Josué Romero-Moreno
Ricardo Josué Romero-Moreno
KTKeelan Trull
Keelan Trull
KWKatharine White
Katharine White
An emerging hallmark of cancer cells is dysregulated pH dynamics. Recent work has suggested that dysregulated intracellular pH (pHi) dynamics enable diverse cancer cellular behaviors at the population level, including cell proliferation, cell migration and metastasis, evasion of apoptosis, and metabolic adaptation. However, the molecular mechanisms driving pH-dependent cancer-associated cell behaviors are largely unknown. In this review article, we explore recent literature suggesting pHi dynamics may play a causative role in regulating or reinforcing tumorigenic transcriptional and proteostatic changes at the molecular level, and discuss outcomes on tumorigenesis and tumor heterogeneity. Most of the data we discuss are population-level analyses; lack of single-cell data is driven by a lack of tools to experimentally change pHi with spatiotemporal control. Data is also sparse on how pHi dynamics play out in complex in vivo microenvironments. To address this need, at the end of this review, we cover recent advances for live-cell pHi measurement at single-cell resolution. We also discuss the essential role for tool development in revealing mechanisms by which pHi dynamics drive tumor initiation, progression, and metastasis.

10 August 2017 in Current Drug Targets
Verified
Journal Article
Closed access
PDF file
TCThomas R. Coughlin
Thomas R. Coughlin
RRRicardo Josué Romero-Moreno
Ricardo Josué Romero-Moreno
DMDevon E. Mason
Devon E. Mason
LNLukas Nystrom
Lukas Nystrom
JBJoel D. Boerckel
Joel D. Boerckel
LLLaurie Littlepage
Laurie Littlepage
Bone is one of the most common and most dangerous sites for metastatic growth across cancer types, and bone metastasis remains incurable. Unfortunately, the processes by which cancers preferentially metastasize to bone are still not well understood. In this review, we summarize the morphological features, physical properties, and cell signaling events that make bone a unique site for metastasis and bone remodeling. The signaling crosstalk between the tumor cells and bone cells begins a vicious cycle – a self-sustaining feedback loop between the tumor cells and the bone microenvironment composed of osteoclasts, osteoblasts, other bone marrow cells, bone matrix, and vasculature to support both tumor growth and bone destruction. Through this crosstalk, bone provides a fertile microenvironment that can harbor dormant tumor cells, sometimes for long periods, and support their growth by releasing cytokines as the bone matrix is destroyed, similar to providing nutrients for a seed to germinate in soil. However, few models exist to study the late stages of bone colonization by metastatic tumor cells. We describe some of the current methodologies used to study bone metastasis, highlighting the limitations of these methods and alternative future strategies to be used to study bone metastasis. While in vivo animal and patient studies may provide the gold standard for studying metastasis, ex vivo models can be used as an alternative to enable more controlled experiments designed to study the late stages of bone metastasis.

14 August 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
RRRicardo Josué Romero-Moreno
Ricardo Josué Romero-Moreno
Brandon CzowskiBrandon Czowski
Brandon Czowski
LHLindsey Harris
Lindsey Harris
JKJessamine F. Kuehn
Jessamine F. Kuehn
KWKatharine White
Katharine White
Intracellular pH (pHi) dynamics regulate normal cell function, and dysregulated pHi dynamics is an emerging hallmark of cancer (constitutively increased pHi) and neurodegeneration (constitutively decreased pHi). However, the molecular mechanisms by which pHi dynamics regulate cell biology are poorly understood. Here, we discovered that altering pHi in normal human breast epithelial cells triggers global transcriptional changes. We identified 176 genes differentially regulated by pHi, with pHi-dependent genes clustering in signaling and glycolytic pathways. Using various normal epithelial cell models, we showed pH-dependent Notch homolog 1 protein expression, with increased protein abundance at high pHi. This resulted in pH-dependent downstream signaling, with increased Notch homolog 1 signaling at high pHi. We also found that high pHi increased the expression of glycolytic enzymes and regulators of pyruvate fate, including lactate dehydrogenase and pyruvate dehydrogenase kinase. These transcriptional changes were sufficient to alter lactate production, with high pHi shifting these normal epithelial cells toward a glycolytic metabolism and increasing lactate production. Thus, pHi dynamics transcriptionally regulate signaling and metabolic pathways in normal epithelial cells. Our data reveal new molecular regulators of pHi-dependent biology and a role for increased pHi in driving the acquisition of cancer-associated signaling and metabolic changes in normal human epithelial cells.

14 April 2026 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
MSMona Hoseini Soflaee
Mona Hoseini Soflaee
RRRicardo Josué Romero-Moreno
Ricardo Josué Romero-Moreno
BCBethany Cheng
Bethany Cheng
NCNathaniel Chavez
Nathaniel Chavez
HHHui‐Lan Hu
Hui‐Lan Hu
MHMichael Handlogten
Michael Handlogten